AcelRx Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for th…

Drug Manufacturers - Specialty & Generic
US, Hayward [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of ACRX's Analysis
CIK: - CUSIP: 00444T100 LEI: - UEI: -
Secondary Listings
ACRX has no secondary listings inside our databases.